ES2149823T3 - Factor y composiciones que afectan al tejido dorsal. - Google Patents
Factor y composiciones que afectan al tejido dorsal.Info
- Publication number
- ES2149823T3 ES2149823T3 ES93922151T ES93922151T ES2149823T3 ES 2149823 T3 ES2149823 T3 ES 2149823T3 ES 93922151 T ES93922151 T ES 93922151T ES 93922151 T ES93922151 T ES 93922151T ES 2149823 T3 ES2149823 T3 ES 2149823T3
- Authority
- ES
- Spain
- Prior art keywords
- seq
- noggine
- noggin
- dorsal
- affect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title 1
- 102000045246 noggin Human genes 0.000 abstract 3
- 108700007229 noggin Proteins 0.000 abstract 3
- 102000005606 Activins Human genes 0.000 abstract 1
- 108010059616 Activins Proteins 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 239000000488 activin Substances 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
SE HA DESCUBIERTO UN POLIPEPTIDO NUEVO Y SOLUBLE QUE ESTA ALTAMENTE CONSERVADO EN VERTEBRADOS Y AL QUE SE DENOMINA "NOGGIN". LAS PROPIEDADES DEL NOGGIN INCLUYEN ACTIVIDAD INDUCTORA DEL CRECIMIENTO DORSAL. NOGGINA Y ACTIVINA ACTUAN SINERGICAMENTE PARA PRODUCIR MESODERMO DORSAL. EL CDNA DE NOGGINA SE HA CLONADO. DISTINTOS SISTEMAS DE EXPRESION SE HAN UTILIZADO EXITOSAMENTE PARA EXPRESAR NOGGINA BIOLOGICAMENTE ACTIVO. LAS SECUENCIAS DE AMINOACIDO QUE REPRESENTAN PORCIONES COMPLETAMENTE CONSERVADAS COMO NOGGINA DE RANA Y NOGGINA DE RATON SON: QMWLWSQTFCPVLY (SEQ ID NO: 3); RFWPRYVKVGSC (SEQ ID NO: 4); SKRSCSVPEGMVCK (SEQ ID NO: 5); LRWRCQRR (SEQ ID NO: 6) Y ISECKCSC (SEQ ID NO: 7).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93995492A | 1992-09-03 | 1992-09-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2149823T3 true ES2149823T3 (es) | 2000-11-16 |
Family
ID=25473995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93922151T Expired - Lifetime ES2149823T3 (es) | 1992-09-03 | 1993-09-02 | Factor y composiciones que afectan al tejido dorsal. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5670481A (es) |
EP (1) | EP0662146B1 (es) |
AT (1) | ATE194658T1 (es) |
AU (1) | AU5125693A (es) |
DE (1) | DE69329031T2 (es) |
DK (1) | DK0662146T3 (es) |
ES (1) | ES2149823T3 (es) |
GR (1) | GR3034554T3 (es) |
PT (1) | PT662146E (es) |
WO (1) | WO1994005800A1 (es) |
ZA (1) | ZA936478B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679783A (en) * | 1994-11-22 | 1997-10-21 | The Regents Of The University Of California | DNA encoding a tissue differentiation affecting factor |
US6133232A (en) * | 1996-06-20 | 2000-10-17 | The Regents Of The University Of California | Endoderm, cardiac and neural inducing factors |
AU6267098A (en) * | 1997-02-05 | 1998-08-25 | Regents Of The University Of California, The | Morphogenic proteins |
IL131420A0 (en) * | 1997-02-19 | 2001-01-28 | Regeneron Pharma | Morphogenic proteins |
US6075007A (en) * | 1997-07-17 | 2000-06-13 | Regeneron Pharmaceuticals, Inc. | Modified noggin polypeptide and compositions |
WO1999061044A1 (en) * | 1998-05-28 | 1999-12-02 | The Board Of Trustees Of The University Of Arkansas | Noggin and antagonists of bone morphogenetic proteins to suppress pathologic bone resorption |
US6087168A (en) | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
EP1615596B1 (en) | 2003-04-11 | 2016-11-02 | Etex Corporation | Osteoinductive bone material |
EP1675608B1 (en) | 2003-09-12 | 2007-03-21 | Wyeth | Injectable calcium phosphate solid rods for delivery of osteogenic proteins |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
WO2007028212A1 (en) * | 2005-09-08 | 2007-03-15 | Apollo Life Sciences Limited | Noggin and chimeric molecules thereof |
US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
WO2007092622A2 (en) | 2006-02-09 | 2007-08-16 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
JP5484047B2 (ja) | 2006-06-30 | 2014-05-07 | バイオミメティック セラピューティクス, エルエルシー | 回旋筋腱板傷害を処置するためのpdgf−生体マトリックス組成物および方法 |
US20090061002A1 (en) | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
BRPI0918611B8 (pt) | 2008-09-09 | 2021-06-22 | Biomimetic Therapeutics Inc | composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit |
CN107080834A (zh) | 2010-02-22 | 2017-08-22 | 生物模拟治疗有限责任公司 | 用于治疗腱病的血小板衍生生长因子组合物和方法 |
US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
US10780171B2 (en) | 2015-10-26 | 2020-09-22 | President And Fellows Of Harvard College | Reduced and oxidized polysaccharides and methods of use thereof |
JP2020502218A (ja) | 2016-12-21 | 2020-01-23 | メレオ バイオファーマ 3 リミテッド | 骨形成不全症の処置における抗スクレロスチン抗体の使用 |
AT521641B1 (de) * | 2018-09-12 | 2020-07-15 | Fianostics Gmbh | Verfahren zur Diagnose von Lebererkrankungen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3934085A (en) * | 1984-01-30 | 1985-08-09 | Icrf Patents Ltd. | Improvements relating to growth factors |
WO1986006096A1 (en) * | 1985-04-11 | 1986-10-23 | The Children's Medical Center Corporation | Von willebrand factor |
US5030576A (en) * | 1986-04-30 | 1991-07-09 | Genentech, Inc. | Receptors for efficient determination of ligands and their antagonists or agonists |
US4857637A (en) * | 1986-05-07 | 1989-08-15 | Genentech, Inc. | Methods and compositions for immunologically modulating growth hormone receptor activity |
IN165717B (es) * | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
US5149637A (en) * | 1987-04-06 | 1992-09-22 | Scripps Clinic & Research Foundation | Recombinant Factor VIIIC fragments |
GB8822147D0 (en) * | 1988-09-21 | 1988-10-26 | Ciba Geigy Ag | Pharmaceutically active combination |
US5098833A (en) * | 1989-02-23 | 1992-03-24 | Genentech, Inc. | DNA sequence encoding a functional domain of a lymphocyte homing receptor |
US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
ATE140966T1 (de) * | 1990-09-25 | 1996-08-15 | Genentech Inc | Neuer neurotropischer faktor |
-
1993
- 1993-09-02 AU AU51256/93A patent/AU5125693A/en not_active Abandoned
- 1993-09-02 EP EP93922151A patent/EP0662146B1/en not_active Expired - Lifetime
- 1993-09-02 DK DK93922151T patent/DK0662146T3/da active
- 1993-09-02 PT PT93922151T patent/PT662146E/pt unknown
- 1993-09-02 ES ES93922151T patent/ES2149823T3/es not_active Expired - Lifetime
- 1993-09-02 AT AT93922151T patent/ATE194658T1/de active
- 1993-09-02 WO PCT/US1993/008325 patent/WO1994005800A1/en active IP Right Grant
- 1993-09-02 ZA ZA936478A patent/ZA936478B/xx unknown
- 1993-09-02 DE DE69329031T patent/DE69329031T2/de not_active Expired - Lifetime
-
1994
- 1994-08-29 US US08/297,633 patent/US5670481A/en not_active Expired - Lifetime
-
2000
- 2000-10-04 GR GR20000402244T patent/GR3034554T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ZA936478B (en) | 1994-09-30 |
WO1994005800A1 (en) | 1994-03-17 |
DK0662146T3 (da) | 2000-11-13 |
DE69329031T2 (de) | 2001-03-22 |
US5670481A (en) | 1997-09-23 |
GR3034554T3 (en) | 2001-01-31 |
EP0662146A4 (en) | 1996-03-13 |
AU5125693A (en) | 1994-03-29 |
DE69329031D1 (de) | 2000-08-17 |
EP0662146B1 (en) | 2000-07-12 |
EP0662146A1 (en) | 1995-07-12 |
PT662146E (pt) | 2000-12-29 |
ATE194658T1 (de) | 2000-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2149823T3 (es) | Factor y composiciones que afectan al tejido dorsal. | |
Vlodavsky et al. | Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. | |
Sommer et al. | Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan | |
Bruckner et al. | The structure of human collagen type IX and its organization in fetal and infant cartilage fibrils. | |
Dion et al. | COOH-terminal propeptides of the major human procollagens: structural, functional and genetic comparisons | |
Jan et al. | Fibromodulin: A regulatory molecule maintaining cellular architecture for normal cellular function | |
YU71395A (sh) | Acilovani analozi insulina | |
DE69128779D1 (de) | Epitheline: neue cystein-reiche, den wachstum modulierende proteine | |
EP0824545A4 (en) | PEPTIDE COMPOUNDS WITH GROWTH FACTOR-LIKE ACTIVITY | |
CN101622007A (zh) | 天然(端肽)胎盘胶原组合物 | |
BG105764A (en) | Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant | |
CA2104678A1 (en) | Protein-induced morphogenesis | |
Miller et al. | Digit tip injuries: current treatment and future regenerative paradigms | |
Bittner et al. | Modulation of collagen gel contraction by decorin | |
JP2012501976A (ja) | ペリオスチンに誘導される膵臓再生 | |
EP1071718A1 (en) | Matrix binding factor | |
Gospodarowicz | Molecular and developmental biology aspects of fibroblast growth factor | |
Strain et al. | Divergent action of transforming growth factor β on DNA synthesis in human foetal liver cells | |
KR890006815A (ko) | 산성 섬유아세포 생장인자의 돌연변이체 | |
Ganassin et al. | Effect of purine supplementation on the growth of salmonid cell lines in different mammalian sera | |
Funderburgh et al. | Corneal glycosaminoglycan synthesis in long-term organ culture. | |
ATE325812T1 (de) | Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors | |
CN1853609B (zh) | 酸性纤维母细胞生长因子(fgf-1)应用于护肤功效 | |
JPWO2009116529A1 (ja) | ポリペプチドおよび当該ポリペプチドを含む医薬組成物 | |
US5459250A (en) | Truncated mammalian growth factor DNA sequence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 662146 Country of ref document: ES |